布地奈德联合复方异丙托溴铵雾化治疗小儿毛细支气管炎疗效观察

Observation on the therapeutic efficacy of budesonide and compound ipratropium bromide inhalated in treatment of inrant bronchiolitis

目的探讨布地奈德联合复方异丙托溴铵雾化治疗小儿毛细支气管炎的疗效。方法 选取2005年1月至2007年2月儿科住院毛细支气管炎患者150例，随机分为治疗组和对照组。两组均采用综合治疗和抗病毒治疗；治疗组给予布地奈德混悬液和复方异丙托溴铵雾化吸入治疗，临床观察对两组疗效进行评价。结果治疗组治愈率为91％，对照组为71％，两组临床疗效比较，差异有统计学意义。结论布地奈德联合复方异丙托溴铵雾化吸入治疗小儿毛细支气管炎是较好的方法。

Objective To discuss the therapeutic efficacy of budesonide and Compound ipratropium bromide inhalated in treatment of infant bronchiolitis. Methods From January 2005 to February 2007,150 infants with bronehiolitis were randomly divided into treated group and control group. Both the two groups were treated with comprehensive treatment and antiviral therapy; control group were treated with budesonide suspension and compound ipratropium bromide inhalated. Clinical efficacy of both two groups was evaluated. Results Cure rate of treatment group was 91%, cure rate of control group was 71%, the clinical therapeutic efficacy were compared between the two groups, the difference of which had statistical significance, Conclusion The result of experiment indicates that the therapeutic efficacy of budesonide and compound ipratropium bromide inhalated in treatment of infant bronchiolitis is better method.